Skip to main content
Fig. 1 | Renal Replacement Therapy

Fig. 1

From: Evaluation of the relationship between hemodialysis-related glycemic variability and hormonal profiles in patients with type 2 diabetes on hemodialysis: a pilot study

Fig. 1

The daily profiles of plasma glucose (A), serum C-peptide (B), plasma glucagon (C), ACTH (D), cortisol (E) and growth hormone (F) in 7 patients with type 2 diabetes undergoing hemodialysis on hemodialysis day (open circle) and non-hemodialysis day (filled circle). *p < 0.05 on hemodialysis day by Wilcoxon signed-rank test; †p < 0.05 on non-hemodialysis day by Wilcoxon signed-rank test; #p < 0.05 derived from the comparison between hemodialysis day and non-hemodialysis day

Back to article page